You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 14, 2025

Details for Patent: 10,149,842


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,149,842 protect, and when does it expire?

Patent 10,149,842 protects VAFSEO and is included in one NDA.

This patent has fifty patent family members in twenty-four countries.

Summary for Patent: 10,149,842
Title:Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
Abstract:Provided herein are solid forms comprising {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders.
Inventor(s):Copp James Densmore, Newman Ann W., Luong Anne
Assignee:Akebia Therapeutics, Inc.
Application Number:US15994348
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a crucial component of intellectual property, providing inventors and companies with exclusive rights to their innovations. To delve into the specifics of a U.S. patent, we will use U.S. Patent 10,149,842 as an example, exploring the broader context of patent valuation, the patent landscape, and the significance of patent claims.

The Value of a Patent

Patents can be highly valuable, and their worth can be determined through several methods: cost, income, and market approaches.

  • Cost Approach: This method considers the costs incurred in developing the patented technology. However, since it is not possible to go back in time to file a patent application, the cost value is essentially what was spent to develop the patent[1].
  • Income Approach: This involves calculating the present value of future benefits derived from the patent, such as revenue or cost savings[1].
  • Market Approach: This method determines the value based on what a willing buyer would pay for a similar asset. Notable examples include the $4.5 billion paid by Rockstar Bidco for 6,000 Nortel patent documents, averaging $750,000 per patent document[1].

Patent Landscape in the United States

The U.S. patent landscape has undergone significant changes, particularly with the enactment of the Leahy-Smith America Invents Act (AIA) in 2011.

  • First-to-Invent vs. First-Inventor-to-File: The AIA transitioned the U.S. patent system from a first-to-invent to a first-inventor-to-file system. This change means that the first person to file a patent application now has priority, regardless of who invented the technology first[2].
  • Impact on Litigation: The AIA also influenced patent infringement litigation. For instance, the number of patent infringement lawsuits increased significantly in 2011, partly due to the anticipation of changes brought about by the AIA. This period saw a rise in lawsuits involving multiple defendants and an increase in cases filed by nonpracticing entities (NPEs)[4].

Patent Claims and Scope

Patent claims are the heart of a patent, defining the scope of protection granted to the inventor.

  • Patent Claims Research Dataset: The USPTO provides detailed datasets on patent claims, including information on claims from U.S. patents granted between 1976 and 2014 and patent applications published between 2001 and 2014. These datasets help in analyzing claim-level statistics and document-level statistics, providing insights into patent scope[3].
  • Importance of Claims: The specificity and breadth of patent claims are critical. Well-crafted claims can significantly impact the enforceability and value of a patent. For example, the Patent Claims Research Dataset allows researchers to analyze the dependency relationships between claims and measure patent scope, which can be vital in assessing the strength and potential value of a patent[3].

Case Study: U.S. Patent 10,149,842

While the specific details of U.S. Patent 10,149,842 are not provided here, we can generalize the analysis based on common practices.

Patent Claims Analysis

  • Claim Structure: Patent claims are typically divided into independent and dependent claims. Independent claims define the broadest scope of the invention, while dependent claims narrow down the scope by adding specific limitations.
  • Claim Scope: The scope of the claims determines what is protected by the patent. Broader claims may offer more comprehensive protection but are also more likely to face challenges during the examination process or in litigation.

Patent Valuation

  • Using the valuation methods mentioned earlier, the value of U.S. Patent 10,149,842 would be assessed based on its development costs, potential future income, and market comparables.
  • Market Comparables: For instance, if the patent is in a highly sought-after technology area like software or biotechnology, it could command a higher price, similar to the $7.7 million paid for a Mobli patent application in 2017[1].

Litigation and Enforcement

  • The AIA's first-inventor-to-file system ensures that the patent holder has clear priority, reducing the likelihood of interference proceedings that were common under the old first-to-invent system[2].
  • Litigation Trends: If U.S. Patent 10,149,842 is involved in litigation, it would likely follow the trends observed in recent years, such as increased involvement of NPEs and a higher number of defendants in patent infringement lawsuits[4].

Key Takeaways

  • Patent Value: Patents can be highly valuable, with values determined through cost, income, and market approaches.
  • Patent Landscape: The U.S. patent system has transitioned to a first-inventor-to-file system, impacting priority and litigation.
  • Patent Claims: The specificity and breadth of patent claims are crucial for determining the scope of protection and the value of a patent.
  • Litigation: Recent trends show an increase in patent infringement lawsuits, particularly involving software-related patents and NPEs.

FAQs

Q: What is the primary difference between the first-to-invent and first-inventor-to-file systems? A: The first-to-invent system granted priority to the first person to invent, while the first-inventor-to-file system grants priority to the first person to file a patent application.

Q: How are patent claims structured? A: Patent claims are typically structured into independent claims, which define the broadest scope of the invention, and dependent claims, which narrow down the scope by adding specific limitations.

Q: What factors contribute to the increase in patent infringement lawsuits? A: Factors include the anticipation of changes brought about by the AIA, an increase in lawsuits involving multiple defendants, and the rise of nonpracticing entities (NPEs) filing lawsuits.

Q: How is the value of a patent determined? A: The value of a patent can be determined through the cost approach (development costs), the income approach (future benefits), and the market approach (comparable sales).

Q: What is the significance of the Patent Claims Research Dataset? A: The dataset provides detailed information on claims from U.S. patents and applications, allowing for the analysis of claim-level statistics and document-level statistics, which is crucial for understanding patent scope and value.

Sources

  1. Perpetual Motion Patents, "The Value of a Patent"
  2. CAFC, "SNIPR TECHNOLOGIES LIMITED v. ROCKEFELLER UNIVERSITY"
  3. USPTO, "Patent Claims Research Dataset"
  4. GAO, "Assessing Factors That Affect Patent Infringement Litigation Could ..."

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,149,842

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Akebia VAFSEO vadadustat TABLET;ORAL 215192-001 Mar 27, 2024 RX Yes No 10,149,842 ⤷  Try for Free Y Y ⤷  Try for Free
Akebia VAFSEO vadadustat TABLET;ORAL 215192-002 Mar 27, 2024 RX Yes No 10,149,842 ⤷  Try for Free Y Y ⤷  Try for Free
Akebia VAFSEO vadadustat TABLET;ORAL 215192-003 Mar 27, 2024 RX Yes Yes 10,149,842 ⤷  Try for Free Y Y ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,149,842

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 099354 ⤷  Try for Free
Argentina 128483 ⤷  Try for Free
Australia 2014348523 ⤷  Try for Free
Australia 2019202144 ⤷  Try for Free
Australia 2020294308 ⤷  Try for Free
Australia 2022259767 ⤷  Try for Free
Brazil 112016011065 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.